Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
02/2005
02/24/2005WO2005016913A1 Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders
02/24/2005WO2005016878A2 METHODS FOR THE PREPARATION OF 5-FLUORO-PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
02/24/2005US20050043398 such as 2-ethoxycarbonyl-7-hydroxychromone, for the care, preservation or improvement of the general state of the skin or hair
02/24/2005US20050043370 Therapy for acquired immune deficiency or aids related complex; compound containing ketone and carboxy groups
02/24/2005US20050043299 Inhibitors of dipeptidyl peptidase iv
02/23/2005EP1508570A1 Novel physiolgically active substances
02/23/2005EP1508327A1 Use of chromen-4-one derivatives for the care of skin and hair
02/23/2005EP1177177B1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
02/23/2005CN1585764A Dimeric compounds and their use as anti-viral agents
02/23/2005CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists
02/22/2005US6858741 Use as pesticides and herbicides
02/22/2005US6858227 Useful in solubilizing lipophilic and relatively water-insoluble compounds; cosmetics, drugs
02/22/2005CA2194043C Compound gex1
02/17/2005WO2005014537A2 Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity
02/17/2005WO2005014517A2 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
02/17/2005WO2005013995A1 4-substituted 7-alkoxy-2-aminosulfonyl-1,2-dihydro-phtalazin derivatives as phosphodiesterase 4 inhibitors for the treatment of allergies and inflammations
02/17/2005WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
02/17/2005US20050038106 polyketides; for inhibiting proliferation of lung cancer or leukemia cells
02/17/2005US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
02/17/2005US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides
02/17/2005US20050037994 Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
02/17/2005CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
02/17/2005CA2534294A1 Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity
02/17/2005CA2533174A1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
02/17/2005CA2530037A1 Podophyllotoxin derivatives
02/16/2005CN1582277A Amide derivatives as glycogen synthase kinase 3-beta inhibitors
02/16/2005CN1580043A Anti malignant tumour southern radix bupleuri extract preparing method
02/10/2005WO2005012291A1 3-amino choman and 2-amino tetralin derivatives
02/10/2005WO2005012280A1 Alkynyl aryl carboxamides
02/10/2005WO2005011670A1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
02/10/2005WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
02/10/2005US20050032873 3-Amino chroman and 2-amino tetralin derivatives
02/10/2005US20050032853 Intermediates for preparing neuraminidase inhibitor conjugates
02/10/2005US20050032176 Modular polyketide synthases with altered activity
02/10/2005CA2533635A1 Novel 6-phenylphenantridines
02/10/2005CA2533363A1 3-amino choman and 2-amino tetralin derivatives
02/10/2005CA2527861A1 Alkynyl aryl carboxamides
02/09/2005EP1105376B1 Oxindole derivatives as growth hormone releasers
02/08/2005US6852711 HIV protease inhibitors
02/03/2005WO2004100998A3 Compositions and methods for non-invasive imaging of soluble beta-amyloid
02/03/2005US20050026997 Baccatin III analog containing a small peptide moiety; can be conjugated to cell binding agents; improved potency
02/03/2005US20050026969 Heterocyclic compounds useful as malonyl-CoA decarboxylase inhibitors
02/02/2005EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors
02/02/2005EP1501795A1 Cinnamic acid amides
02/02/2005EP1501791A1 Amino acid analogues
02/02/2005EP1501786A1 Biphenyl carboxamides
02/01/2005US6849652 1,2,4-triazole derivative or a non-toxic salt thereof as an active ingredient for treatment of fever, pain, and inflammation
02/01/2005US6849621 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
01/2005
01/27/2005WO2005007635A2 Combretastatin derivatives with cytotoxic action
01/27/2005US20050020635 C7 carbamoyloxy substituted taxane compositions
01/27/2005US20050020629 Pain management
01/27/2005US20050017216 Liquid crystals; using metastasis catalysts; reduction, hydrogenation
01/27/2005CA2531389A1 Combretastatin derivatives with cytotoxic action
01/26/2005EP1500655A1 New methionine aminopeptidase inhibitor
01/26/2005EP1499609A2 Pesticidal heterocycles
01/26/2005CN1571667A Inhibitors of dipeptidyl peptidase ó¶
01/26/2005CN1570774A Organophotoreceptor with a charge transport compound having an epoxy group
01/26/2005CN1186340C C10 carbonate substituted taxanes as antitumor agents
01/25/2005CA2129455C Orally active azole derivatives
01/20/2005WO2005005418A1 Benzofuran derivatives and their use in the treatment of microbial infections
01/20/2005US20050014833 Cyclic compound and ppar agonist
01/20/2005US20050014757 Serotonin receptor antagonist; psychological disorders; side effect reduction
01/20/2005US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
01/20/2005US20050013879 Method for extracting antineoplastic components from Bupleurum scorzonerifolium
01/20/2005CA2531757A1 Benzofuran derivatives and their use in the treatment of microbial infections
01/19/2005CN1568325A Cross-linked glycopeptide-cephalosporin antibiotics
01/19/2005CN1566109A Aldose reductase inhibitor, preparation method and use thereof
01/18/2005US6844173 Strain of Streptomyces griseus
01/18/2005CA2158458C Taxanes prepared by beta-lactams and ammonium alkoxides
01/13/2005US20050009920 Taxol enhancer compounds
01/13/2005US20050009855 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives; these compounds interfere with the E1-E2-DNA complex during initiation of DNA replication
01/13/2005US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
01/12/2005EP1495019A1 Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
01/12/2005EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors
01/12/2005CN1184219C Taxusane phoshponic oxygen methyl ether derivant
01/06/2005WO2005000831A1 ESTERS OF FLAVONOIDS WITH ω-SUBSTITUTED C6-C22 FATTY ACIDS
01/06/2005US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
01/06/2005CA2531020A1 Cannabinoid receptor modulator
01/05/2005CN1561338A Chroman derivatives as 5-hydroxytryptamine-6 ligands
01/05/2005CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
01/04/2005US6838474 Prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. This invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and
12/2004
12/30/2004US20040266820 quinolin-2-ones and chromen-2-ones compounds that have been derivatized at the 6-position with a urea or thiourea derivative; used as androgen antagonists; kits
12/30/2004US20040266764 Hydroxamic acid derivatives
12/29/2004WO2004113320A1 Cannabinoid derivatives, methods of making, and use thereof
12/29/2004WO2004113316A1 Benzofuran inhibitors of factor viia
12/29/2004WO2004075853A3 Halogenated triptolide derivatives as immunomodulators and anticancer agents
12/29/2004WO2004075815A3 Diarylcycloalkyl derivatives, method for their production and their use as medicaments
12/29/2004EP1490350A1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
12/29/2004EP1490341A1 Novel adamantane derivatives
12/29/2004EP1490339A1 Novel chalcone derivatives and uses thereof
12/29/2004EP1490334A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
12/29/2004EP1490047A2 Certain pharmaceutically useful substituted aminoalkyl heterocycles
12/29/2004CN1558898A Antiviral agent
12/29/2004CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/29/2004CN1557808A 3-substituted piperazine triadimenol antifungal compounds and their salts
12/29/2004CN1182129C Benzopyran derivatives having leukotriene-antagonistic action
12/29/2004CA2526103A1 Cannabinoid derivatives, methods of making, and use thereof
12/29/2004CA2525713A1 Benzofuran inhibitors of factor viia
12/28/2004US6835845 Methine compound, material for organic luminescence element, and organic luminescence element using the same
12/28/2004US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 120